J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
health.economictimes.indiatimes14m
Alembic Pharma gets USFDA nod for generic medication
The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of ...
The Financial Express33m
USDA gives nod to Alembic Pharma’s generic formulation to treat seizures
Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.
MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme
Dr. David Holbrook brings a wealth of experience to the MitoRx board with a background spanning global business development at leading companies such as GlaxoSmithKline and Roche, and extensive ...